Request Demo
Last update 23 Jan 2025
HRS-5041
Last update 23 Jan 2025
Overview
Basic Info
Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms |
Target |
Mechanism AR antagonists(Androgen Receptor antagonists) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
6
Clinical Trials associated with HRS-5041NCT06738745
A Phase II Study of HRS-2189 Combined HRS-5041 in Metastatic Prostate Cancer
NCT06559007
A Phase 1, Open-Label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Dose HRS-5041 in Healthy Caucasian Male Participants
NCT06568094
An Open, Multicenter Phase Ib/II Study on the Safety, Tolerability and Efficacy of HRS-5041 Tablets Combined With Antitumor Therapy in Subjects With Advanced Prostate Cancer
100 Clinical Results associated with HRS-5041
Login to view more data
100 Translational Medicine associated with HRS-5041
Login to view more data
100 Patents (Medical) associated with HRS-5041
Login to view more data
100 Deals associated with HRS-5041
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Prostate Carcinoma | Phase 2 | CN | 06 Sep 2024 | |
| Prostatic Cancer | Phase 1 | AU | 25 Sep 2024 | |
| Metastatic castration-resistant prostate cancer | Phase 1 | CN | 15 Sep 2023 | |
| Advanced cancer | IND Approval | CN | 18 Oct 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free